LogoLogo
  • Company Overview
  • Business Overview
    • Global Threat of GI Cancers
    • Market Opportunity
    • The Need for AI Integration
    • AI-Powered Early Detection System
    • Competitive Advantage of Apex AI
  • Commercialization Strategy
    • Phased Commercialization Plan
    • Global Expansion Strategy
  • Appendix
    • Token Utility
    • Tokenomics
    • Company Timeline
    • Intellectual Property
Powered by GitBook
On this page
Export as PDF
  1. Commercialization Strategy

Phased Commercialization Plan

Apex AI's business model is structured into multiple phases, ensuring gradual market penetration, regulatory compliance, and long-term scalability.

Phase 1: New Medical Devices (Pre-Market Stage)

Apex AI is focused on early strategic partnerships and data integration before obtaining regulatory approvals.

Revenue Model

Implementation

Business Partners

Integration with healthcare platforms (e.g., “Doctorbase” by iKooB)

Embedded as a service-based AI platform

Healthcare platform providers

Software sales to hospitals & clinical institutions

Direct sales of clinical support AI software

Medical device distributors

Licensing & data sales to medical device companies

Licensing AI technology for endoscopy & dialysis imaging systems

Endoscopy device manufacturers, AI medical companies

Phase 2: Medical Device Approval & Expansion

Once regulatory approvals are obtained, Apex AI will shift towards direct clinical integration and cloud-based AI services.

Revenue Model

Implementation

Business Partners

Software licensing & cloud services

Post-approval integration with hospitals, clinics, and insurance providers

Hospitals, health screening centers, insurers

PreviousCompetitive Advantage of Apex AINextGlobal Expansion Strategy

Last updated 3 months ago